All articles tagged with #space medicine
Miniature human organs, including hearts and brains, launched to the International Space Station on Tuesday to study how microgravity and radiation accelerate aging. This first-of-its-kind experiment aims to improve health outcomes for future astronauts and develop treatments for diseases like Parkinson's and Alzheimer's on Earth.
A University of Copenhagen and NASA study found that microgravity slows intestinal movement, causing gut bacteria to ferment protein instead of fiber. This shift, detected in blood samples from 52 ISS astronauts, explains common space constipation and poses risks for long-duration missions to Mars.
Researchers at New York University have demonstrated that human cells maintain stable genome organization after 24 hours in simulated microgravity, challenging previous assumptions about immediate genetic damage in space. By using a custom random-positioning machine that minimizes fluid currents, the team isolated the effects of gravity from mechanical stress, finding no detectable DNA damage or disruption to the nuclear envelope. While the nucleus expanded and the nucleolus smoothed, these changes were distinct from the DNA damage caused by fluid flow in traditional rotating cultures. This finding supports the emerging concept of treating gravity as a variable 'dose' for health, though experts caution that long-duration spaceflight involves additional factors like radiation that this short-term experiment did not replicate.
A space-medicine expert explains that handling a crew member’s death varies by mission: on the ISS remains could be returned to Earth within hours, on the Moon within a few days, and on a Mars mission likely only at the end of the mission with the body preserved aboard in a dedicated chamber. Death in vacuum outside a suit is instantaneous, and cremation or burial on other worlds presents energy and contamination challenges, so preservation and eventual return are prioritized. The piece also notes the need for grieving support for families and thorough planning for future space colonization.
Four first-time astronauts aboard SpaceX Fram2 used a portable X-ray unit with roughly four hours of training to capture diagnostic images in orbit; three radiologists on the ground judged the images clinically usable to identify fractures or foreign objects, marking the first in-space diagnostic X-rays and highlighting portable imaging as a key tool for future deep-space missions where hospital care is unreachable.
The Fram2 mission aboard SpaceX’s Crew Dragon achieved the first in-space X-rays. Four crew members, with about four hours of training, used a portable X-ray device to image a smartwatch, a hand, an abdomen, a pelvis, and a chest in orbit. The resulting images were good enough to aid injury diagnosis and hardware checks, and the device survived launch and re-entry with minimal damage. Experts say portable, rugged, compact X-ray systems could boost crew health care on future missions and even improve medical access on Earth in rural areas; researchers aim to further shrink and harden the technology. The study was published in Radiology on July 14.
SpaceX’s Fram2 mission conducted the first in-orbit medical X-ray scans with a portable X-ray device, capturing diagnostic-quality images of the hand, forearm, abdomen, pelvis, and chest that were reviewed by three radiologists. The inflight results show radiography can supplement ultrasound for astronaut health, diagnose injuries, and even assess equipment or space-suit integrity, marking a path toward more capable space diagnostics. Future work will aim to miniaturize and harden X-ray systems for vacuum and deep-space use, with real-time imaging guidance for astronauts on Moon missions.
Returning astronauts often feel burning sole pain and lower-back ache within days of landing as swollen intervertebral discs in microgravity are suddenly compressed by Earth's gravity; skin loses its Earth-hardening calluses and the vestibular system re-calibrates, making first steps unsteady. Pain typically peaks around days 2–4 as discs rehydrate and recompress while paraspinal muscles re-adjust. The risk of herniated discs is highest in the first year post-flight, especially in the cervical spine. Recovery follows a pattern: stand soon after splashdown but walk unsteadily for days, height returns to normal in about 10 days, and bone density recovery lags behind. Artemis missions and future Mars transits will face these challenges without on-site ground support, requiring careful postflight conditioning.
Shenzhou-23 astronauts Zhu Yangzhu, Zhang Zhiyuan and Li Jiaying carried out multi-disciplinary experiments (microbiome and nutrient metabolism, visual-motion and microgravity perception, emotional recognition and emergency decision-making), completed in-orbit medical emergency training, and conducted extensive maintenance of life-support systems and health checks on the China Space Station.
Valeri Polyakov’s 437 days aboard the Mir space station (1994–95) remains the longest continuous human spaceflight and was explicitly designed to validate a round-trip Mars mission. He tracked and countered physiological effects—bone density and muscle loss, cardiovascular changes, and Spaceflight-Associated Neuro-ocular Syndrome—while refining exercise and medical protocols. He walked unaided from the Soyuz after 14.5 months, declaring that “We can fly to Mars.” Since then, no mission has exceeded 437 days, as modern programmes favor shorter rotations due to radiation and risk management. The acquired data remains the essential baseline for future Mars missions, now targeted for the early 2030s, leaving Polyakov’s record as a historic milestone waiting for practical application.
NASA astronaut Mike Fincke experienced a sudden speech disturbance aboard the ISS and returned to Earth early on the SpaceX Crew-11 mission. While no formal diagnosis was disclosed, NASA and space medicine experts say the incident highlights how weightlessness and radiation pose complex health risks that may affect future deep-space missions. As agencies plan longer journeys to the Moon and Mars, there is growing emphasis on onboard medical capabilities, Earth‑linked support, and emerging tools like organ chips to monitor and tailor care for astronauts on extended missions.
A veteran NASA astronaut, Michael Fincke, suddenly lost the ability to speak aboard the International Space Station for about 20 minutes, triggering emergency protocols and NASA’s first in-orbit medical evacuation. No cause was identified, highlighting the limits of space medicine and raising concerns about health risks on longer missions like Artemis II.
NASA is investigating a mid-January medical episode in which Pittsburgh astronaut Mike Fincke suddenly couldn't speak aboard the International Space Station; doctors ruled out a heart attack, but the exact cause remains unknown after ultrasound tests and extensive medical reviews, prompting an early return for Fincke and the canceled spacewalk for crewmates—though Fincke says he feels fine and hopes to fly again one day.
NASA astronaut Michael Fincke suffered a sudden, unexplained medical episode on the ISS that left him unable to speak. Doctors ruled out a heart attack, and the crew returned to Earth early, with the incident underscoring the need for robust medical systems as NASA plans longer lunar missions under Artemis II.
NASA says veteran astronaut Mike Fincke experienced a sudden medical scare during the SpaceX Crew-11 mission and re-entry, but the cause remains unclear as investigators review what happened ahead of a safe splashdown near San Diego on January 15, 2026.